Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;20(2):88-92.
doi: 10.2174/1871529X19666191210110626.

Total Ankle Replacement in Hemophilia

Affiliations

Total Ankle Replacement in Hemophilia

Emerito C Rodriguez-Merchan. Cardiovasc Hematol Disord Drug Targets. 2020.

Abstract

Introduction: Severe ankle hemophilic arthropathy can be a calamitous sign of severe hemophilia with important inferences for activities of daily living.

Aims: To summarize the contemporary, accessible information on Total Ankle Replacement (TAR) for ankle hemophilic arthropathy.

Methods: A search of Cochrane Library and PubMed (MEDLINE) regarding the role of TAR in ankle hemophilic arthropathy.

Results: The insufficient information regarding the results of TAR for hemophilic arthropathy is confined to scanty case series and case reports. An evaluation of the accessible literature reveals encouraging but inconstant outcomes. The reported rate of adverse events is 33%. The reported anticipated survival of TAR is 94% at 5 years, 85% at 10 years and 70% at 15 years.

Conclusion: Whereas people with advanced hemophilic arthropathy of the ankle are prone to ameliorate pain and range of motion following TAR, there is deficient knowledge to regularly recommend its use. Adverse events and infection percentages are disturbing. Moreover, the lack of survival analysis knowledge makes it difficult to assess the benefit to people with hemophilia. TAR is a demanding surgical procedure and its survival is not comparable to that after hip or knee replacement.

Keywords: Hemophilia; ankle; hemarthrosis; hemophilic arthropathy; rheumatoid arthritis; total ankle replacement..

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Flow chart of our search strategy regarding the role of Total Ankle Replacement (TAR) in hemophilia (17 October 2018).

Similar articles

Cited by

References

    1. Rodríguez-Merchán E.C. The role of orthopaedic surgery in haemophilia: Current rationale, indications and results. EFORT Open Rev. 2019;4(5):165–173. doi: 10.1302/2058-5241.4.180090. - DOI - PMC - PubMed
    1. Barg A., Morris S.C., Schneider S.W., Phisitkul P., Saltzman C.L. Surgical procedures in patients with haemophilic arthropathy of the ankle. Haemophilia. 2016;22(3):e156–e176. doi: 10.1111/hae.12919. - DOI - PubMed
    1. Rodriguez-Merchan E.C. Ankle surgery in haemophilia with special emphasis on arthroscopic debridement. Haemophilia. 2008;14(5):913–919. doi: 10.1111/j.1365-2516.2008.01820.x. - DOI - PubMed
    1. Rodriguez-Merchan E.C., Gomez-Cardero P., Martinez-Lloreda Á., De La Corte-Rodriguez H., Jimenez-Yuste V. Arthroscopic debridement for ankle haemophilic arthropathy. Blood Coagul. Fibrinolysis. 2015;26(3):279–281. doi: 10.1097/MBC.0000000000000230. - DOI - PubMed
    1. Rodriguez-Merchan E.C. Management of hemophilic arthropathy of the ankle. Cardiovasc. Hematol. Disord. Drug Targets. 2017;17(2):111–118. doi: 10.2174/1871529X17666170908110758. - DOI - PubMed